JOGEX | RNPAX | JOGEX / RNPAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 23 years | - |
Gain YTD | 1.482 | 2.034 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 29.3M | 145B | 0% |
Annual Yield % from dividends | 1.38 | 0.47 | 296% |
Returns for 1 year | -6.81 | 14.12 | -48% |
Returns for 3 years | -35.13 | -0.09 | 40,699% |
Returns for 5 years | -23.17 | 26.11 | -89% |
Returns for 10 years | -11.47 | 67.88 | -17% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSCRX | 25.24 | 0.09 | +0.36% |
Fidelity Small Cap Discovery | |||
WFPCX | 43.81 | 0.15 | +0.34% |
Allspring Special Mid Cap Value C | |||
ICEWX | 37.81 | 0.03 | +0.08% |
NYLI Epoch International Choice Class C | |||
GFSIX | 16.07 | N/A | N/A |
Gabelli Global Financial Services I | |||
FBTDX | 106.93 | -0.13 | -0.12% |
Franklin Biotechnology Discovery C |